Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.9B
| $2.08M | ﹤0.01% |
63,400
+48,100
| +314% | +$1.4M |
|
|
AFCG
1927
AFC Gamma
AFCG
$72.1M
| $2.07M | ﹤0.01% |
251,876
+70,993
| +39% | +$559K |
|
|
YSG
1928
Yatsen Holding
YSG
$319M
| $2.07M | ﹤0.01% |
566,149
-6,920
| -1% | -$29.6K |
|
1929
Benchmark Electronics
BHE
$2.94B
| $2.07M | ﹤0.01% |
74,800
-39,950
| -35% | -$1.01M |
|
1930
abrdn Physical Gold Shares ETF
SGOL
$7.47B
| $2.06M | ﹤0.01% |
+104,598
| New | +$1.98M |
|
1931
Franklin FTSE Japan ETF
FLJP
$4.14B
| $2.06M | ﹤0.01% |
+73,700
| New | +$1.97M |
|
1932
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.1B
| $2.06M | ﹤0.01% |
35,300
+16,800
| +91% | +$917K |
|
1933
CytomX Therapeutics
CTMX
$732M
| $2.06M | ﹤0.01% |
1,325,700
+395,600
| +43% | +$520K |
|
|
RNAM
1934
DELISTED
Avidity Biosciences
RNAM
| $2.05M | ﹤0.01% |
226,700
+115,900
| +105% | +$775K |
|
1935
Rackspace Technology
RXT
$1.07B
| $2.05M | ﹤0.01% |
1,025,600
-490,234
| -32% | -$741K |
|
1936
Nokia
NOK
$60.1B
| $2.05M | ﹤0.01% |
599,400
-5,226,200
| -90% | -$17.7M |
|
1937
AnaptysBio
ANAB
$1.73B
| $2.05M | ﹤0.01% |
95,600
+2,900
| +3% | +$50K |
|
1938
Valhi
VHI
$459M
| $2.05M | ﹤0.01% |
134,717
-2,500
| -2% | -$33K |
|
|
API
1939
Agora
API
$392M
| $2.04M | ﹤0.01% |
777,100
-5,800
| -0.7% | -$16.2K |
|
|
MITT
1940
TPG Mortgage Investment Trust
MITT
$215M
| $2.04M | ﹤0.01% |
321,640
+141,540
| +79% | +$769K |
|
|
SILK
1941
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $2.04M | ﹤0.01% |
166,300
-41,300
| -20% | -$387K |
|
1942
Avantis US Equity ETF
AVUS
$14.5B
| $2.04M | ﹤0.01% |
25,000
+12,700
| +103% | +$961K |
|
1943
Republic Bancorp
RBCAA
$1.92B
| $2.04M | ﹤0.01% |
36,900
-4,200
| -10% | -$200K |
|
1944
Boston Omaha
BOC
$421M
| $2.03M | ﹤0.01% |
129,062
-49,438
| -28% | -$751K |
|
|
CHMI
1945
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $2.03M | ﹤0.01% |
502,584
+2,700
| +0.5% | +$9.79K |
|
1946
iShares ESG Aware MSCI EM ETF
ESGE
$6.84B
| $2.03M | ﹤0.01% |
63,300
-3,500
| -5% | -$108K |
|
1947
i3 Verticals
IIIV
$319M
| $2.03M | ﹤0.01% |
95,800
+27,673
| +41% | +$555K |
|
1948
Liberty Broadband Class A
LBRDA
$5.21B
| $2.02M | ﹤0.01% |
+25,100
| New | +$2.11M |
|
1949
Nice
NICE
$5.99B
| $2.02M | ﹤0.01% |
10,144
-39,900
| -80% | -$7.18M |
|
1950
Alto Ingredients
ALTO
$324M
| $2.01M | ﹤0.01% |
755,000
+103,300
| +16% | +$329K |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.